Brain ischemia and reperfusion activate the immune system. The abrupt development of brain ischemic lesions suggests that innate immune cells may shape the outcome of stroke. Natural killer (NK) cells are innate lymphocytes that can be swiftly mobilized during the earliest phases of immune responses, but their role during stroke remains unknown. Herein, we found that NK cells infiltrated the ischemic lesions of the human brain. In a mouse model of cerebral ischemia, ischemic neuron-derived fractalkine recruited NK cells, which subsequently determined the size of brain lesions in a T and B cell-independent manner. NK cell-mediated exacerbation of brain infarction occurred rapidly after ischemia via the disruption of NK cell tolerance, augmenting local inflammation and neuronal hyperactivity. Therefore, NK cells catalyzed neuronal death in the ischemic brain.
Brain ischemia and reperfusion activate the immune system. The abrupt development of brain ischemic lesions suggests that innate immune cells may shape the outcome of stroke. Natural killer (NK) cells are innate lymphocytes that can be swiftly mobilized during the earliest phases of immune responses, but their role during stroke remains unknown. Herein, we found that NK cells infiltrated the ischemic lesions of the human brain. In a mouse model of cerebral ischemia, ischemic neuron-derived fractalkine recruited NK cells, which subsequently determined the size of brain lesions in a T and B cell-independent manner. NK cell-mediated exacerbation of brain infarction occurred rapidly after ischemia via the disruption of NK cell tolerance, augmenting local inflammation and neuronal hyperactivity. Therefore, NK cells catalyzed neuronal death in the ischemic brain.
innate immunity | middle cerebral artery occlusion | ischemic stroke B rain hypoxia during stroke activates innate and adaptive immune responses via induction of a transcriptional reprogramming of genes that encode oxygen-sensing prolyl-hydroxylase enzymes (1) , which in turn promote posttranscriptional activation of inflammatory signaling pathways that control the stability of hypoxia-induced factor 1 and nuclear factor-κB (1) . At the cellular level, ischemia, reperfusion, and cell death trigger a cascade of events that include the release of acute inflammatory mediators, such as TNF, IL-1β, arachidonic acid metabolites, reactive oxygen species (ROS), nitric oxide, and matrix metalloproteinases, up-regulation of adhesion molecules E-and P-selectin on endothelial cells, and breakdown of the bloodbrain barrier (1) (2) (3) . These events lead to leukocyte extravasation, the engagement of pattern-recognition molecules such as Tolllike receptors, activation of the complement system, and recruitment and activation of lymphocytes (1) . In this context it has recently been shown that adaptive immune T and B cells exacerbate stroke lesions (4-6), whereas regulatory T cells seem to confer a protective role in late stages of stroke (7) .
Ischemia-triggered brain tissue damage occurs rapidly (i.e., within hours after the cessation of blood and oxygen supply), well before the activation of antigen-specific T and B cells. It is therefore challenging to understand how adaptive lymphocytes contribute to stroke in acute stages, before becoming primed with brain antigens. It is also not clear how regulatory T cells provide protection in late stages of stroke, when lesions have become stable (5, 8) . IL-17-producing γδ T cells have been shown to play a pivotal role in the delayed phase of ischemic brain injury, but not in the early stages (8) . Natural killer (NK) T cells, a subpopulation of T cells with an invariant T-cell receptor, seem not to impact stroke (5) . Notably, the abrupt development of brain lesions suggests that innate immune cells may shape infarct formation in the early stages of stroke. However, little is known to date about the roles of specific innate lymphocyte subsets early in a stroke's inception. NK cells are CD3
-innate lymphocytes and among the first immune cells that respond to a pathogen insult. NK cells orchestrate both the innate and adaptive immune responses via their cytolytic activity without prior sensitization and produce an early burst of cytokines. Moreover, NK cells readily home to the central nervous system (CNS) in numerous neurological conditions (9) . Given the prompt nature of the NK cell response and rapid evolution of stroke lesions, we postulated that NK cells would play a major role in stroke.
Results
Accumulation of NK Cells in the Cerebral Infarct in Stroke. To address the possible function of NK cells during strokes, we stained NKp46 + NK cells in brain slices from patients with acute middle cerebral artery ischemic stroke. NKp46 (NCR1, CD335) is a specific NK cell marker both in humans and in mice (10) . By using immunofluorescence staining, we found that NKp46 + cells infiltrated the infarct and periinfarct areas ( Fig. 1 A, B , and D), accumulating in close proximity to ischemic neurons (Fig. 1C) . In mice, we induced a standard 90-min reversible ischemia (occlusion-reperfusion) via transient middle cerebral artery occlusion (MCAO) (7, 8, 11) . Seven-Tesla (7T) rodent MRI was used in conjunction with 2,3,5-triphenyltetrazolium chloride (TTC) staining (Fig. S1 ) to measure infarct size. The diffusion and perfusion
Significance
Stroke is a devastating illness second only to cardiac ischemia as a cause of death worldwide. Long-time attempts to salvage dying neurons and preserve neurological functions via various neuroprotective agents have failed, owing at least in part to medical science's limited knowledge of ischemia-induced elements that participate in irreversible neurovascular damage. The present study was performed to understand the role of natural killer (NK) cells, a key member of the innate immune system, in stroke. We discovered that NK cells infiltrated the brains of stroke patients and mice with induced stroke. Multiple pathways by which NK cells exacerbate brain infarction are discovered. This study revealed the role of NK cells in the pathogenesis of stroke. deficit detected 24 h after MCAO by apparent diffusion coefficient and the cerebral blood flow maps of 7T MRI showed a mismatch (approximates ischemic penumbra) at sites where most cells infiltrated (Fig. 1E) . Immunostaining revealed accumulations of NKp46 + cells in the periinfarct areas (Fig.  1F, Right) .
To further confirm the infiltration of NK cell, we induced MCAO in NK1.1-tdTomato transgenic mice, in which a red fluorescent protein (tdTomato) reporter gene was knocked into the NK1.1 allele (Fig. S2 A and B) . NK1.1 (NKR-P1C) is a marker of NK cells in C57BL/6 mice (12). First, flow cytometry analysis confirmed that NK1.1-tdTomato + cells from the transgenic mouse were also NKp46 + (Fig. S2C) . Next, MCAO induction in NK1.1-tdTomato mice resulted in NK1.1-tdTomato + NK cells infiltration throughout the infarct hemisphere, principally localized in periinfarct areas (Fig. 1G) . Kinetic experiments showed that NK cells accumulated as early as 3 h after MCAO, peaked at day 3 after MCAO, then moderately declined ( Fig. 1 H  and I ). Of note, NK cells were still detectable as late as 30 d after MCAO (Fig. 1I) . These results indicate that NK cells rapidly accumulate in the ischemic brain. CX3CL1 is the main chemokine attracting CX3CL1 receptor (CX3CR1)-expressing NK cells to the CNS (13, 14) . In line with previous reports that neurons are the major source of CX3CL1 in the brain (15), we found that the infarcted hemisphere contained a significantly larger amount of CX3CL1 than the contralateral hemisphere in brain sections (Fig. 2 A and B) and in brain homogenates (Fig. 2C) of MCAO mice. Next, NK cell chemotaxis to CX3CL1 was confirmed in vitro by coculture of cortical neurons and NK cells in a transwell migration assay (16) . Cultured cortical neurons were subjected to hypoxic conditions by combined oxygen-glucose deprivation (OGD) for 60 min, a condition that mimics ischemia in vivo. The results from transwell migration assays showed that OGD neuron-conditioned medium attracted CX3CR1-bearing (Cx3cr1 +/+ ) but not CX3CR1-deficient (Cx3cr1 −/− ) NK cells. Moreover, the migration of Cx3cr1 +/+ NK cells toward OGD neurons was inhibited by anti-CX3CL1 mAb (Fig. 2D) Fig. S4 ). Thus, enhanced production of CX3CL1 by ischemic neurons attracts NK cells into brain lesions through the presence of CX3CR1 in acute stroke. Fig. 3 A and C) and less neurological deficits (Fig. 3B) than Rag2 −/− mice, suggesting that NK cells might favor cerebral infarction independently of T, NKT, and B cells. The observed effects on infarct lesions persisted for at least 7 d after MCAO (Fig. 3C) . This result suggests that the detrimental effects of NK cells in stroke are independent of T, NKT, and B cells.
Having determined that NK cell-homing to the ischemic brain is mediated by CX3CR1 (Fig. 2) , we further pursued the role of NK cells in stroke by passively transferring Cx3cr1 +/+ NK cells into Rag2 −/− γc −/− mice and then inducing MCAO. Notably, the adoptive transfer of Cx3cr1 +/+ , but not Cx3cr1 −/− NK cells, significantly increased brain infarct size in Rag2 Fig. 3 A and C) , further supporting the concept that the extent of homing of NK cells to the brain in stroke affects infarct size.
To confirm that NK cells determine infarct size in stroke, we induced ischemia in WT mice given anti-NK1.1 mAb 2 d before the induction of MCAO. NK1.1 + cells (NK and NKT cells) can be efficiently depleted with anti-NK1.1 mAb, as previously reported (16) . WT mice treated with isotype IgG served as controls. In MCAO mice treated with anti-NK1.1 mAb, we found smaller infarcts and milder neurological deficits than in the IgG controls (Fig. 3 D and E) . Because NKT cells do not influence stroke significantly (5), the observed effects of anti-NK1.1 mAb treatment can be attributed to NK cell depletion. Taken together, these data demonstrate that NK cells are a key lymphocyte determinant of brain infarct size in stroke.
Detrimental Effect of NK Cells on Stroke Has a ∼12-h Limit. To define the time window during which NK cells exert their impact on stroke, we administered anti-NK1.1 mAb to deplete NK cells (16) or isotype control IgG to groups of mice at 6, 12, and 24 h after MCAO. We found that NK cell depletion at 6 h after MCAO attenuated neurological deficits and infarct volume (Fig.  3 D-G) , similarly to the NK cells depletion 2 d before MCAO shown above. Hence, attenuation was pronounced within the first 12 h after MCAO (Fig. 3 D-G) .
Ischemic Neurons Ablate NK Cell Tolerance. To define the mechanisms governing NK cell-mediated detrimental effects, we first assessed whether NK cells could augment stroke through cytolytic effects on neurons. For that purpose, cortical neurons exposed to OGD were cocultured with NK cells. Morphologically the formation of NK cell-neuron complexes resembled the immune synapse, and the presence of NK cells promoted damage to cell bodies and axons (Fig. 4A) .
Because cortical neurons are relatively resistant to NK cellmediated killing (17) , the neural death observed in the cultures of NK cell-ischemic neurons prompted us to investigate a possible loss of NK cell tolerance, by analyzing the expression of inhibitory or stimulatory receptors on NK cells and their ligands on neurons. Of note, expression of the self MHC class Ib molecule Qa1, the ligand for natural-killer group 2A (NKG2A) receptor, decreased significantly on ischemic neurons (Fig. 4B) . NKG2A, an inhibitory receptor coupled to CD94, was similar on NK cells from the contralateral and ischemic hemispheres, whereas natural-killer group 2D protein (NKG2D), an activation receptor, increased on NK cells in the ischemic hemisphere (Fig. 4 C and D) . The NK cell-mediated cytolytic killing of ischemic neurons was then confirmed by 51 Cr release assay (Fig. 4E) , and overexpression of Qa1 using lentiviral transfection (Fig. S5 ) abrogated NK cell-mediated killing of neurons (Fig. 4E) . Therefore, NK cell-mediated neuronal damage is associated with the loss of self-identity for ischemic neuron-modulated NK cell tolerance and the activation of NK cells (i.e., up-regulated NKG2D expression).
To confirm the cytolytic effects of NK cells on ischemic neurons in vivo, we again took advantage of the adoptive transfer model using Rag2 −/− γc −/− mice as recipients. To this end, we focused on perforin, a cytolytic protein found in the granules of NK cells and an important player in NK cell-mediated cytolysis (18) . Rag2 −/− γc −/− mice manipulated to develop MCAO were given perforin −/− NK (Pfr −/− NK) cells and 24 h later developed brain lesions that were obviously smaller than those in their counterparts given WT NK cells (Fig. 5) .
NK Cell-Derived IFN-γ Contributes to Brain Infarction. In addition to the cytolytic effects on neurons, NK cells could augment local inflammation through release of proinflammatory cytokines. We , and 24 h after reperfusion, respectively. Treatment regimen and efficiency of cell depletion are described elsewhere (16, 30) . Neurological deficits (D and F) were assessed, and infarct volumes (E and G) were determined by MRI in conjunction with TTC staining. Attenuation was more pronounced when NK cells were depleted preceding MCAO or within the first 12 h after MCAO. n = 8 per group. **P < 0.01. MCAO mice had lower levels of IFN-γ, IL-17A, TNF-α, IL-1β, IL-6, IL-12, macrophage inflammatory protein 1α and 1β (MIP-1α, -1β), and monocyte chemotactic protein 1β (MCP-1β) than the corresponding controls, and these alterations persisted to later stages of stroke (Fig. 6A) . However, the levels of tumor growth factor β (TGF-β) were not significantly altered. Reductions of IL-1β and IL-6 were also verified by immunohistochemical staining in brain sections from Rag2 −/− and Rag2 (Fig. 6 B-E) . Generation of ROS, a key factor that activates cell death pathways, was also reduced in MCAO mice by a lack of NK cells (Fig. 6 F and G) .
Previous studies have asserted that IFN-γ augments lesion size in mice with MCAO (6). We reasoned that NK cell is a major source of IFN-γ that may boost local inflammation, as demonstrated above. We therefore reconstituted Rag2 (Fig. 5) .
NK Cells Enhance Ischemic Neuronal Excitability and Synaptic Excitatory
Transmission. We also examined the intrinsic neuronal membrane excitability that could be associated with hyperactivity and neuronal death by using somatic whole-cell current-clamp recording. Interestingly, we found that coculture with NK cells after OGD exposure significantly increased the excitability of cortical neurons in response to injected currents relative to that of OGD neurons cultured alone without NK cells (Fig. 7 A and C) .
To test the effects of NK cells on synaptic excitatory activities, we next examined AMPA [2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid] receptor-mediated miniature excitatory postsynaptic currents (mEPSCs). A significant increase in mEPSC frequency was observed in OGD-exposed cortical neurons cocultured with NK cells compared with OGD-exposed neurons without NK cells in culture (Fig. 7 B and E) . However, mEPSC amplitude was not changed (Fig. 7 B and D) . In addition, we found that NK cell-mediated effects on neuronal hyperactivities were independent of perforin (Fig. S6) . This marked increase of mEPSC frequency in OGD neurons that were cocultured with NK cells could result from the enhanced release of presynaptic vesicular glutamate, thereby potentiating glutamatemediated excitotoxicity and contributing to NK cell-mediated neuronal death (19) .
Discussion
This study provides previously unidentified evidence that NK cells exert a detrimental impact that results in neuronal death, ischemic brain lesions, and the neurological deficit typical of stroke. As documented here, ischemic neuron-derived CX3CL1 played a major role in recruiting NK cells to its close proximity. Loss of NK cell tolerance was promoted by local inflammatory foci, following a reduced expression of MHC class Ib molecules on the ischemic neurons, as well as up-regulation of the activating receptor NKG2D on NK cells. All together, the above events led to NK cell-mediated cytotoxicity and increased neuronal death (20) , a process also seen in viral encephalitis (9, 21) . Additionally, NK cells orchestrated local inflammatory responses that could, in turn, further aggravate edema and hypoxia in the ischemic penumbra. Last but not least, NK cells increased neuronal excitability and synaptic excitatory transmission in the ischemic brain-a finding that is reminiscent of seizure disorder in some stroke patients, together with an increased oxygen demand Cr release assay. Target cells (cultured control neurons, ischemic neurons, or Qa1 overexpressing ischemic neurons) were labeled with 51 Cr. Effector cells were the IL-2 (10 μg/mL), IL-15 (10 μg/mL), and LPS (5 μg/mL) activated NK cells. Cytotoxicity was measured at 10:1; 5:1 and 1:1 (effector:target) ratio. Each value represents the mean ± SEM of the response of NK cells from three individual cell culture wells. Data represent four separate experiments. **P < 0.01 vs. control neuron.
# P < 0.05 vs. ischemic neuron. of dying neurons, which hastened their demise. This aspect is important because neuronal cell hyperactivity has been implicated in brain ischemia-induced neuronal death (19) . The initiation and progression of the cellular and biochemical events that lead to inflammatory responses and irreversible cell death are swift processes that occur within minutes to hours after the onset of ischemic brain stroke (22) . Temporal considerations suggest that only the immune cells that can be activated without the requirement of antigen priming could respond rapidly to the ischemic events during the acute phases of the process. NK cells have these characteristics. T cells that do not need classic antigen presentation for activation, such as NKT and γδ T cells, are also capable of responding in the acute phase of stroke. However, CD1d-deficient mice lacking NKT cells were not protected from ischemic injury 24 h after MCAO, suggesting that NKT cells were not involved in the early phases of injury (5) . Conversely, the involvement of γδ T cells occurred on day 4, which is a late stage of cerebral infarction (8) . Interestingly, the data presented here suggest that NK cells contribute to the genesis of brain lesions at the very initiation of stroke.
In addition to a direct killing of hypoxic neurons, NK cells might directly or indirectly cooperate with immigrant cells or brain-resident cells during hypoxia and cell death. For examples, NK cells might act in synergy with monocytes and platelets to propagate thrombosis and activate the complement system in response to brain ischemia and reperfusion (3) . Additionally, the release of IFN-γ by NK cells might activate other fractalkineguided homing of cells to the brain, including inflammatory macrophages (23); IFN-γ could also augment MHC class II molecules on dendritic cells, which might influence the adaptive immune response (24) . Whether and how NK cells interact with microglia or other brain-intrinsic cells to impact infarct development is of interest and warrants further investigation.
The present finding that NK cells promoted inflammation and neuronal damage in stroke indicated distinctive activity of NK cells during experimental autoimmune encephalomyelitis (EAE) (16, 25) , a mouse model of human multiple sclerosis. In EAE, NK cells, together with myelin-reactive T cells, are activated in the periphery before they migrate to the brain. Autoreactive T and B cells, as well as other lymphocytes (including NK cells and regulatory T lymphocytes) that directly or indirectly modify the magnitude of autoimmunity, ultimately determine the extent of demyelination. By contrast, the cellular and biochemical cascade triggered by ischemia leading to neuronal death begins within the brain, and NK cells are recruited with a timing and inflammatory microenvironment that differ from those in EAE. These aspects may modify NK cell phenotype and function (24) . Additionally, the different role played by NK cells in the two diseases can relate to the target tissue, primary disease-initiating factors, timing of the immune responses, and the overall autoimmune process (24) .
To conclude, as presented here, the extensive infiltration of NK cells in periinfarct areas of the brain during acute ischemic stroke, together with these cells' physical proximity to damaged neurons, suggests a detrimental role for NK cells in ischemic brain. However, for clinical translation, several critical issues were generated 12 h after MCAO, with seven mice per group. **P < 0.01. were from patients who died within 7 d after acute stroke following MCAO, and the other 6 cases were from individuals who died from nonneurological diseases and who were used as controls. The nonneurological disease patients in present study had no history of neurological or neuropsychiatric disease. In addition, histopathological examination confirmed no pathological changes in brain sections beyond those expected in "control" nonneurological disease. Stroke patients and control subjects did not differ significantly in terms of their mean age at death (stroke patients, 79.4 ± 8.5 y; controls, 83.2 ± 9.1 y, mean ± SEM; P > 0.05, Student t test). Brain tissues were collected within 4 h after death.
Mice. Male C57BL/6 (B6) mice and Rag2 ), and Ifn-γ −/− mice were purchased from The Jackson Laboratory. All mutant mice were back-crossed to the B6 background for 8-12 generations. Details of mice used in this study are given in SI Materials and Methods.
MCAO Procedure, Neuroimaging, and Clinical and Neuropathological Assessment. Adult male mice (age 2-3 mo) were subjected to a 90-min transient ischemia (occlusion-reperfusion) by MCAO using the filament method, as previously described (7, 8, 11, 27) . Details of the MCAO procedures, TTC staining, MRI scan, ROS measurement, neurological deficit assessment, and immunohistochemistry staining are provided in SI Materials and Methods.
In Vivo Cell Depletion and Cell Passive Transfer, in Vitro NK Cell-Mediated Cytotoxicity, ELISA, and Flow Cytometry. NK cell depletion and NK cell, microglia passive transfer were performed in vivo (16, (28) (29) (30) . Detailed protocols for 51 Cr release assay (16) , electrophysiology (31, 32) , ELISA, and flow cytometry are given in SI Materials and Methods.
Statistics. Details of statistical analyses are given in SI Materials and Methods.
Significance was set at P < 0.05. Data are shown as means ± SEM.
